| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 8.42e-11 | 4 | 62 | 4 | GO:0003873 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 4.20e-10 | 5 | 62 | 4 | GO:0004331 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 2.93e-09 | 7 | 62 | 4 | GO:0008443 | |
| GeneOntologyMolecularFunction | sugar-phosphatase activity | 1.74e-08 | 10 | 62 | 4 | GO:0050308 | |
| GeneOntologyMolecularFunction | carbohydrate phosphatase activity | 2.74e-08 | 11 | 62 | 4 | GO:0019203 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 4.85e-07 | 21 | 62 | 4 | GO:0019200 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 7.22e-04 | 229 | 62 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.24e-03 | 68 | 62 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 1.24e-03 | 386 | 62 | 6 | GO:0042578 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.29e-03 | 69 | 62 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.40e-03 | 71 | 62 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | phosphatase activity | 1.96e-03 | 287 | 62 | 5 | GO:0016791 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 3.17e-03 | 27 | 62 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.17e-03 | 27 | 62 | 2 | GO:0005044 | |
| GeneOntologyBiologicalProcess | fructose 2,6-bisphosphate metabolic process | 1.10e-09 | 6 | 62 | 4 | GO:0006003 | |
| GeneOntologyBiologicalProcess | fructose metabolic process | 1.31e-07 | 16 | 62 | 4 | GO:0006000 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 1.98e-07 | 208 | 62 | 8 | GO:0009166 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 2.64e-07 | 216 | 62 | 8 | GO:1901292 | |
| GeneOntologyBiologicalProcess | carbohydrate phosphorylation | 8.93e-07 | 25 | 62 | 4 | GO:0046835 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 1.19e-06 | 114 | 62 | 6 | GO:0046032 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 1.39e-06 | 117 | 62 | 6 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 1.39e-06 | 117 | 62 | 6 | GO:0009181 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 1.61e-06 | 120 | 62 | 6 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 1.69e-06 | 121 | 62 | 6 | GO:0009191 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | 1.92e-06 | 281 | 62 | 8 | GO:0046434 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 1.95e-06 | 124 | 62 | 6 | GO:0009134 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 2.81e-06 | 132 | 62 | 6 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 2.81e-06 | 132 | 62 | 6 | GO:0009179 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 4.46e-06 | 143 | 62 | 6 | GO:0009185 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 5.66e-06 | 149 | 62 | 6 | GO:0009132 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide catabolic process | 1.16e-05 | 169 | 62 | 6 | GO:0009154 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 1.18e-05 | 257 | 62 | 7 | GO:0046034 | |
| GeneOntologyBiologicalProcess | ribonucleotide catabolic process | 1.56e-05 | 178 | 62 | 6 | GO:0009261 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 1.77e-05 | 182 | 62 | 6 | GO:0006195 | |
| GeneOntologyBiologicalProcess | glycolytic process | 2.00e-05 | 110 | 62 | 5 | GO:0006096 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 2.13e-05 | 188 | 62 | 6 | GO:0072523 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide metabolic process | 2.18e-05 | 112 | 62 | 5 | GO:1900542 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 2.19e-05 | 283 | 62 | 7 | GO:0009205 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide metabolic process | 2.28e-05 | 113 | 62 | 5 | GO:0006140 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 2.56e-05 | 290 | 62 | 7 | GO:0009199 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 2.62e-05 | 291 | 62 | 7 | GO:0009144 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 2.92e-05 | 119 | 62 | 5 | GO:0019364 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 3.19e-05 | 202 | 62 | 6 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 3.19e-05 | 202 | 62 | 6 | GO:0019362 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 3.43e-05 | 123 | 62 | 5 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 3.69e-05 | 307 | 62 | 7 | GO:0009141 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 3.95e-05 | 696 | 62 | 10 | GO:0034655 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 3.96e-05 | 210 | 62 | 6 | GO:0072524 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 5.09e-05 | 323 | 62 | 7 | GO:1901136 | |
| GeneOntologyBiologicalProcess | lipoprotein particle mediated signaling | 5.31e-05 | 4 | 62 | 2 | GO:0055095 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle mediated signaling | 5.31e-05 | 4 | 62 | 2 | GO:0055096 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 6.80e-05 | 142 | 62 | 5 | GO:0006090 | |
| GeneOntologyBiologicalProcess | negative regulation of purine nucleotide biosynthetic process | 8.84e-05 | 5 | 62 | 2 | GO:1900372 | |
| GeneOntologyBiologicalProcess | negative regulation of nucleotide biosynthetic process | 8.84e-05 | 5 | 62 | 2 | GO:0030809 | |
| GeneOntologyBiologicalProcess | negative regulation of purine nucleotide metabolic process | 1.21e-04 | 32 | 62 | 3 | GO:1900543 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 1.26e-04 | 646 | 62 | 9 | GO:0005975 | |
| GeneOntologyBiologicalProcess | negative regulation of nucleotide metabolic process | 1.32e-04 | 33 | 62 | 3 | GO:0045980 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 1.35e-04 | 652 | 62 | 9 | GO:0072521 | |
| GeneOntologyBiologicalProcess | cytokine production involved in immune response | 1.50e-04 | 168 | 62 | 5 | GO:0002367 | |
| GeneOntologyBiologicalProcess | type II interferon production | 1.54e-04 | 169 | 62 | 5 | GO:0032609 | |
| GeneOntologyBiologicalProcess | regulation of ATP metabolic process | 1.63e-04 | 91 | 62 | 4 | GO:1903578 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 1.94e-04 | 684 | 62 | 9 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 2.09e-04 | 691 | 62 | 9 | GO:0006753 | |
| GeneOntologyBiologicalProcess | regulation of purine nucleotide biosynthetic process | 2.36e-04 | 40 | 62 | 3 | GO:1900371 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide biosynthetic process | 2.36e-04 | 40 | 62 | 3 | GO:0030808 | |
| GeneOntologyBiologicalProcess | carbohydrate catabolic process | 3.07e-04 | 196 | 62 | 5 | GO:0016052 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 3.33e-04 | 310 | 62 | 6 | GO:0005996 | |
| GeneOntologyBiologicalProcess | positive regulation of ATP metabolic process | 4.06e-04 | 48 | 62 | 3 | GO:1903580 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 4.50e-04 | 767 | 62 | 9 | GO:0055086 | |
| GeneOntologyBiologicalProcess | urate transport | 4.80e-04 | 11 | 62 | 2 | GO:0015747 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 5.10e-04 | 619 | 62 | 8 | GO:0006163 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ENPP1 ENTPD1 PFKFB1 PFKFB2 PFKFB3 PFKFB4 APP PIK3R5 CNP VCP RD3 | 5.37e-04 | 1142 | 62 | 11 | GO:0019637 |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide metabolic process | 6.07e-04 | 55 | 62 | 3 | GO:0045981 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide metabolic process | 6.07e-04 | 55 | 62 | 3 | GO:1900544 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 7.37e-04 | 999 | 62 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 8.42e-04 | 512 | 62 | 7 | GO:0009150 | |
| GeneOntologyBiologicalProcess | immune effector process | 1.01e-03 | 859 | 62 | 9 | GO:0002252 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | 1.02e-03 | 529 | 62 | 7 | GO:0006091 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 1.06e-03 | 533 | 62 | 7 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 1.15e-03 | 540 | 62 | 7 | GO:0019693 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization | 1.16e-03 | 263 | 62 | 5 | GO:1903828 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 1.22e-03 | 155 | 62 | 4 | GO:0032649 | |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | 1.31e-03 | 403 | 62 | 6 | GO:0002440 | |
| GeneOntologyBiologicalProcess | spontaneous synaptic transmission | 1.32e-03 | 18 | 62 | 2 | GO:0098814 | |
| GeneOntologyBiologicalProcess | microglia differentiation | 1.32e-03 | 18 | 62 | 2 | GO:0014004 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.36e-03 | 896 | 62 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | cytokine production | TRIL PGLYRP4 SLC11A1 ENPP1 DTX4 CD36 ASH1L APP ARID5A ZNF287 | 1.44e-03 | 1091 | 62 | 10 | GO:0001816 |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.63e-03 | 741 | 62 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.63e-03 | 284 | 62 | 5 | GO:0019318 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 1 type immune response | 1.63e-03 | 20 | 62 | 2 | GO:0002827 | |
| GeneOntologyBiologicalProcess | regulation of generation of precursor metabolites and energy | 1.68e-03 | 169 | 62 | 4 | GO:0043467 | |
| MousePheno | increased variability of skeletal muscle fiber size | 1.75e-05 | 43 | 51 | 4 | MP:0009403 | |
| MousePheno | decreased cardiac muscle glycogen level | 3.91e-05 | 3 | 51 | 2 | MP:0014072 | |
| Domain | 6Pfruct_kin | 1.10e-10 | 4 | 62 | 4 | IPR003094 | |
| Domain | 6Phosfructo_kin | 1.10e-10 | 4 | 62 | 4 | IPR013079 | |
| Domain | 6PF2K | 1.10e-10 | 4 | 62 | 4 | PF01591 | |
| Domain | PG/BPGM_mutase_AS | 1.37e-08 | 9 | 62 | 4 | IPR001345 | |
| Domain | PGAM | 2.28e-08 | 10 | 62 | 4 | SM00855 | |
| Domain | PG_MUTASE | 2.28e-08 | 10 | 62 | 4 | PS00175 | |
| Domain | His_Phos_1 | 5.34e-08 | 12 | 62 | 4 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 5.34e-08 | 12 | 62 | 4 | IPR013078 | |
| Domain | His_PPase_superfam | 5.12e-07 | 20 | 62 | 4 | IPR029033 | |
| Domain | - | 5.12e-07 | 20 | 62 | 4 | 3.40.50.1240 | |
| Domain | BAH | 5.64e-06 | 11 | 62 | 3 | SM00439 | |
| Domain | BAH | 5.64e-06 | 11 | 62 | 3 | PF01426 | |
| Domain | BAH | 5.64e-06 | 11 | 62 | 3 | PS51038 | |
| Domain | BAH_dom | 5.64e-06 | 11 | 62 | 3 | IPR001025 | |
| Domain | SANT | 6.11e-04 | 50 | 62 | 3 | SM00717 | |
| Domain | SANT/Myb | 6.86e-04 | 52 | 62 | 3 | IPR001005 | |
| Domain | ZnF_GATA | 7.00e-04 | 12 | 62 | 2 | SM00401 | |
| Domain | ELM2 | 8.26e-04 | 13 | 62 | 2 | PF01448 | |
| Domain | ELM2 | 8.26e-04 | 13 | 62 | 2 | PS51156 | |
| Domain | ELM2_dom | 8.26e-04 | 13 | 62 | 2 | IPR000949 | |
| Domain | ELM2 | 8.26e-04 | 13 | 62 | 2 | SM01189 | |
| Domain | - | 9.62e-04 | 14 | 62 | 2 | 2.60.40.1180 | |
| Domain | Glyco_hydro_b | 1.11e-03 | 15 | 62 | 2 | IPR013780 | |
| Domain | Znf_GATA | 1.11e-03 | 15 | 62 | 2 | IPR000679 | |
| Domain | GATA | 1.11e-03 | 15 | 62 | 2 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 1.26e-03 | 16 | 62 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 1.26e-03 | 16 | 62 | 2 | PS50114 | |
| Domain | Ez/rad/moesin-like | 2.19e-03 | 21 | 62 | 2 | IPR000798 | |
| Domain | FERM_CS | 2.85e-03 | 24 | 62 | 2 | IPR019747 | |
| Domain | FERM_C | 3.35e-03 | 26 | 62 | 2 | PF09380 | |
| Domain | SANT_dom | 3.35e-03 | 26 | 62 | 2 | IPR017884 | |
| Domain | FERM_C | 3.61e-03 | 27 | 62 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 3.61e-03 | 27 | 62 | 2 | IPR018980 | |
| Domain | SANT | 3.88e-03 | 28 | 62 | 2 | PS51293 | |
| Domain | FERM_N | 5.36e-03 | 33 | 62 | 2 | PF09379 | |
| Domain | FERM_N | 5.36e-03 | 33 | 62 | 2 | IPR018979 | |
| Domain | Myb_DNA-binding | 6.01e-03 | 35 | 62 | 2 | PF00249 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 6.79e-08 | 12 | 50 | 4 | M27950 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 6.00e-06 | 34 | 50 | 4 | M15898 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.00e-04 | 82 | 50 | 4 | MM15394 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.29e-04 | 85 | 50 | 4 | M1870 | |
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 9464277 | ||
| Pubmed | 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. | 9.77e-12 | 4 | 63 | 4 | 7574501 | |
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 10095107 | ||
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 2837207 | ||
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 15896703 | ||
| Pubmed | 1.22e-09 | 9 | 63 | 4 | 21074528 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 14623077 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 30819197 | ||
| Pubmed | PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. | 3.15e-07 | 8 | 63 | 3 | 36115843 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 21835916 | ||
| Pubmed | Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain. | 3.23e-06 | 2 | 63 | 2 | 11245921 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15331593 | ||
| Pubmed | Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells. | 3.23e-06 | 2 | 63 | 2 | 28152500 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20015873 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 22846899 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 38813509 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8830046 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 17991424 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15059642 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15925437 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 1647027 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29516286 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8814283 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16311927 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 26449856 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 25160621 | ||
| Pubmed | 4.72e-06 | 1116 | 63 | 11 | 31753913 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 28315680 | ||
| Pubmed | Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner. | 9.68e-06 | 3 | 63 | 2 | 21203512 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 9202079 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17143338 | ||
| Pubmed | [EXPRESSION OF PFKFB, HK2, NAMPT, TSPAN13 AND HSPB8 GENES IN PEDIATRIC GLIOMA]. | 1.93e-05 | 4 | 63 | 2 | 27491149 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 11522786 | ||
| Pubmed | Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks. | 1.93e-05 | 4 | 63 | 2 | 19282473 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 26827442 | ||
| Pubmed | 2.46e-05 | 31 | 63 | 3 | 36127325 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 34385591 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 18039179 | ||
| Pubmed | A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. | 3.22e-05 | 5 | 63 | 2 | 12239221 | |
| Pubmed | Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease. | 4.82e-05 | 6 | 63 | 2 | 37258678 | |
| Pubmed | 6.18e-05 | 42 | 63 | 3 | 35705031 | ||
| Pubmed | TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function. | 6.74e-05 | 7 | 63 | 2 | 29518356 | |
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 38587131 | ||
| Pubmed | Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. | 1.44e-04 | 10 | 63 | 2 | 25974097 | |
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 20037584 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 24349473 | ||
| Pubmed | Quantification of synapse formation and maintenance in vivo in the absence of synaptic release. | 2.49e-04 | 13 | 63 | 2 | 15145078 | |
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 2.90e-04 | 14 | 63 | 2 | 28263302 | |
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 20548946 | ||
| Pubmed | 4.41e-04 | 195 | 63 | 4 | 19454010 | ||
| Pubmed | 4.87e-04 | 551 | 63 | 6 | 34728620 | ||
| Pubmed | 5.24e-04 | 1297 | 63 | 9 | 33545068 | ||
| Pubmed | 5.41e-04 | 19 | 63 | 2 | 15647280 | ||
| Pubmed | 5.41e-04 | 19 | 63 | 2 | 25660456 | ||
| Pubmed | Identification of type 2 diabetes-associated combination of SNPs using support vector machine. | 6.14e-04 | 91 | 63 | 3 | 20416077 | |
| Pubmed | 6.63e-04 | 21 | 63 | 2 | 22467210 | ||
| Pubmed | Unassembled CD147 is an endogenous endoplasmic reticulum-associated degradation substrate. | 6.63e-04 | 21 | 63 | 2 | 23097496 | |
| Pubmed | 7.97e-04 | 23 | 63 | 2 | 31281901 | ||
| Pubmed | 7.97e-04 | 23 | 63 | 2 | 14966270 | ||
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 8.80e-04 | 103 | 63 | 3 | 22623531 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 8.86e-04 | 235 | 63 | 4 | 28378594 | |
| Pubmed | 9.43e-04 | 25 | 63 | 2 | 15935055 | ||
| Pubmed | 9.43e-04 | 25 | 63 | 2 | 23968980 | ||
| Pubmed | 9.43e-04 | 25 | 63 | 2 | 19876004 | ||
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 1.10e-03 | 27 | 63 | 2 | 23395962 | |
| Pubmed | TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. | 1.18e-03 | 28 | 63 | 2 | 29653964 | |
| Pubmed | 1.18e-03 | 28 | 63 | 2 | 30277474 | ||
| Pubmed | 1.24e-03 | 660 | 63 | 6 | 32780723 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.39e-03 | 1489 | 63 | 9 | 28611215 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 1.46e-03 | 269 | 63 | 4 | 30442662 | |
| Pubmed | 1.55e-03 | 32 | 63 | 2 | 18842294 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 1.75e-03 | 1242 | 63 | 8 | 30973865 | |
| Interaction | PFKFB1 interactions | 1.08e-06 | 26 | 61 | 4 | int:PFKFB1 | |
| Interaction | PFKFB3 interactions | 1.80e-06 | 67 | 61 | 5 | int:PFKFB3 | |
| Interaction | PFKFB4 interactions | 5.19e-06 | 38 | 61 | 4 | int:PFKFB4 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 4.01e-11 | 4 | 47 | 4 | 1077 | |
| GeneFamily | Olfactory receptors, family 52 | 2.79e-04 | 49 | 47 | 3 | 165 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.52e-04 | 53 | 47 | 3 | 532 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.80e-04 | 15 | 47 | 2 | 82 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.52e-03 | 34 | 47 | 2 | 487 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.48e-03 | 50 | 47 | 2 | 1293 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN | 6.77e-06 | 198 | 61 | 6 | M9234 | |
| CoexpressionAtlas | Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3 | 1.93e-05 | 425 | 58 | 8 | GSM538255_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 2.51e-05 | 441 | 58 | 8 | GSM605862_500 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.86e-07 | 176 | 63 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 170 | 63 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 6.12e-06 | 183 | 63 | 5 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 6.12e-06 | 183 | 63 | 5 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.80e-06 | 187 | 63 | 5 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.34e-06 | 190 | 63 | 5 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.53e-06 | 191 | 63 | 5 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.12e-06 | 194 | 63 | 5 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-06 | 194 | 63 | 5 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | control-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.12e-06 | 194 | 63 | 5 | 2218e6677dc6781a6e4ef3a315f2298cc2cd9df2 | |
| ToppCell | COVID-19-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 8.33e-06 | 195 | 63 | 5 | 4a7c080230ce6a79335ecbeadecb0177b2c13625 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-06 | 197 | 63 | 5 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.75e-06 | 197 | 63 | 5 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.75e-06 | 197 | 63 | 5 | a902aa05e5f711bcfdd9e19749ab636b597eb116 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.97e-06 | 198 | 63 | 5 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-06 | 199 | 63 | 5 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 200 | 63 | 5 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 200 | 63 | 5 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-05 | 125 | 63 | 4 | 9e98dcfdc768ae492f453efc08926164bbb0a909 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.57e-05 | 164 | 63 | 4 | 3a4ecc632be003d09b765c992804134348d2278b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.57e-05 | 164 | 63 | 4 | 4b10b78d4d76023c3c5bcd427757218fdd5465ca | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.63e-05 | 169 | 63 | 4 | 818ab7a6fd1940a22d3bd99fe15f0af888af6b3e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.63e-05 | 169 | 63 | 4 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.63e-05 | 169 | 63 | 4 | f982f2e0d341fa27229f443ebe5c0e4a9e63bda6 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 173 | 63 | 4 | f0eb48c1283bdde313bb75f6ffc0d2626922d24b | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 174 | 63 | 4 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.08e-04 | 174 | 63 | 4 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 174 | 63 | 4 | 2f25fba5225f4687df4396645e94565a640b5583 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 176 | 63 | 4 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.23e-04 | 180 | 63 | 4 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 1.23e-04 | 180 | 63 | 4 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | Severe-Myeloid-mDC|Severe / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 181 | 63 | 4 | 00f2949b609ac21bd2da6fd8f685739eeb2f48ad | |
| ToppCell | Severe-Myeloid-mDC-|Severe / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 181 | 63 | 4 | 51ded98c76ec35ab1d24ac3ab98280381daa9831 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.28e-04 | 182 | 63 | 4 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 185 | 63 | 4 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 185 | 63 | 4 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.39e-04 | 186 | 63 | 4 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.39e-04 | 186 | 63 | 4 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.45e-04 | 188 | 63 | 4 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 1.51e-04 | 190 | 63 | 4 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | MS-pDC-|MS / Condition, Cell_class and T cell subcluster | 1.51e-04 | 190 | 63 | 4 | f56ec302d556ace4f7609017a35c311cf43aa8a5 | |
| ToppCell | MS-pDC|MS / Condition, Cell_class and T cell subcluster | 1.51e-04 | 190 | 63 | 4 | f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 191 | 63 | 4 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.57e-04 | 192 | 63 | 4 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.57e-04 | 192 | 63 | 4 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 192 | 63 | 4 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 192 | 63 | 4 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | IPF-Myeloid-cDC2|IPF / Disease state, Lineage and Cell class | 1.57e-04 | 192 | 63 | 4 | fe1de692fec48cba4a9bbc6eaa257260e8b4e800 | |
| ToppCell | CD8+_Memory_T_cell-RSV-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.57e-04 | 192 | 63 | 4 | 6357af0fb60a13a0ac727bc922b7606ab520ef5c | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 192 | 63 | 4 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 192 | 63 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 1.60e-04 | 193 | 63 | 4 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 1.60e-04 | 193 | 63 | 4 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.60e-04 | 193 | 63 | 4 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 1.60e-04 | 193 | 63 | 4 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 1.64e-04 | 194 | 63 | 4 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | Control-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 1.64e-04 | 194 | 63 | 4 | 7ab808dd1876b0eec2831caa16d04fd859b1dc50 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.64e-04 | 194 | 63 | 4 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 1.64e-04 | 194 | 63 | 4 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 195 | 63 | 4 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.67e-04 | 195 | 63 | 4 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-04 | 195 | 63 | 4 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 195 | 63 | 4 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | myeloid-CD14+_Monocyte|myeloid / Lineage and Cell class | 1.67e-04 | 195 | 63 | 4 | 60fab0c24c827567fb42bbd7eb165bf45178c198 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 195 | 63 | 4 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | Control-Myeloid-MoAM4|Control / Condition, Lineage and Cell class | 1.67e-04 | 195 | 63 | 4 | 211a736acbe875bd3c1942c62aaacc9b170ece6d | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 1.67e-04 | 195 | 63 | 4 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.70e-04 | 196 | 63 | 4 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 196 | 63 | 4 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 196 | 63 | 4 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-04 | 196 | 63 | 4 | 799f54131fb1034f82ef4872cfb2c64359541086 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-04 | 196 | 63 | 4 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 197 | 63 | 4 | c6645db1bfb5a352cfbb8d83fd1929dcfd41e216 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 197 | 63 | 4 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 197 | 63 | 4 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 197 | 63 | 4 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 197 | 63 | 4 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.74e-04 | 197 | 63 | 4 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 197 | 63 | 4 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 197 | 63 | 4 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 197 | 63 | 4 | 72cd61b868d57862ec9c230ea68913d3829b0f2b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 198 | 63 | 4 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 198 | 63 | 4 | 0b928a829844f49f4d47e88908af192cb919011f | |
| ToppCell | Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma|Caecum / shred on region, Cell_type, and subtype | 1.77e-04 | 198 | 63 | 4 | 3893fcfc1de5937be3ccc7e545f711f2c95a2827 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 198 | 63 | 4 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|Caecum / Region, Cell class and subclass | 1.77e-04 | 198 | 63 | 4 | d8cb78b1763710a158cf22b59aebaa44afd2374c | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 1.77e-04 | 198 | 63 | 4 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-04 | 199 | 63 | 4 | 0b20ae65b9340d844e271acda9e116d98fc1cc69 | |
| ToppCell | Control-Control-Others-RBC|Control / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | eb4c52d04f572433c0239bf479d0040a309939a1 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.80e-04 | 199 | 63 | 4 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 199 | 63 | 4 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-04 | 199 | 63 | 4 | bb9e7418468b88cdfaa78788d062362794ea8230 | |
| ToppCell | Sepsis-URO-Myeloid-pDC|URO / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | 1dc96a1cc313fa175fe50f0df606baa84ea5970b | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-pDC|ICU-NoSEP / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | a199e67438eeed903d0996605591ec54400fdd66 | |
| Drug | glipentide | 1.73e-09 | 7 | 62 | 4 | CID000065779 | |
| Drug | 2-MP | 3.46e-09 | 8 | 62 | 4 | CID003015569 | |
| Drug | fructose 2-phosphorothioate 6-phosphate | 1.62e-08 | 11 | 62 | 4 | CID000195184 | |
| Drug | carboxytolbutamide | 4.89e-08 | 14 | 62 | 4 | CID000159651 | |
| Drug | PK-F | 4.89e-08 | 14 | 62 | 4 | CID000448133 | |
| Drug | Thr-Ala | 6.65e-08 | 15 | 62 | 4 | CID006427021 | |
| Drug | dibenzyl succinate | 8.85e-08 | 16 | 62 | 4 | CID000007653 | |
| Drug | N-bromoacetylethanolamine phosphate | 1.16e-07 | 17 | 62 | 4 | CID000188343 | |
| Drug | AC1L1AO2 | 1.48e-07 | 18 | 62 | 4 | CID000001073 | |
| Drug | brazilin | 1.48e-07 | 18 | 62 | 4 | CID000073384 | |
| Drug | melarsen oxide | 5.08e-07 | 24 | 62 | 4 | CID000030830 | |
| Drug | mitiglinide | 8.35e-07 | 27 | 62 | 4 | CID000121891 | |
| Drug | mantATP | 2.45e-06 | 35 | 62 | 4 | CID000123756 | |
| Drug | Laevuflex | 9.02e-06 | 272 | 62 | 7 | CID000003426 | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; HL60; HG-U133A | 1.60e-05 | 197 | 62 | 6 | 1986_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; HL60; HG-U133A | 1.64e-05 | 198 | 62 | 6 | 1970_DN | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.69e-05 | 199 | 62 | 6 | 3730_UP | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.74e-05 | 200 | 62 | 6 | 7544_DN | |
| Drug | 3-phosphohistidine | 1.77e-05 | 57 | 62 | 4 | CID000123911 | |
| Drug | 1,6-di-o-phosphonohexopyranose | 2.80e-05 | 64 | 62 | 4 | CID000000737 | |
| Drug | AC1L19C4 | 3.77e-05 | 69 | 62 | 4 | CID000000483 | |
| Drug | titanium trichloride | 4.36e-05 | 4 | 62 | 2 | CID000062646 | |
| Drug | 1 sulfonylurea | 4.42e-05 | 143 | 62 | 5 | CID011819083 | |
| Drug | fructose-1,6-diphosphate sodium salt | 5.73e-05 | 151 | 62 | 5 | CID000000718 | |
| Drug | allulose 6-phosphate | 8.00e-05 | 162 | 62 | 5 | CID000000603 | |
| Drug | phorbol acetate myristate | P2RX1 PNN ENPP1 CD36 PES1 ICAM4 PFKFB1 PFKFB2 PFKFB3 PFKFB4 APP SLC23A1 TOP3A | 8.27e-05 | 1399 | 62 | 13 | CID000004792 |
| Drug | sodium azide | 8.56e-05 | 85 | 62 | 4 | CID000033557 | |
| Drug | troglitazone | 8.70e-05 | 526 | 62 | 8 | CID000005591 | |
| Drug | 2-hexulofuranose | 9.79e-05 | 88 | 62 | 4 | CID000000716 | |
| Drug | Murnac-tripeptide | 1.52e-04 | 7 | 62 | 2 | CID000119512 | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A | 1.69e-04 | 190 | 62 | 5 | 1990_DN | |
| Drug | ara-Hx | 1.82e-04 | 193 | 62 | 5 | CID000000804 | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 5774_UP | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 2260_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 4644_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 2628_DN | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 5045_UP | |
| Drug | diiodomethane | 2.02e-04 | 8 | 62 | 2 | CID000006346 | |
| Drug | Orange I | 2.02e-04 | 8 | 62 | 2 | CID005359467 | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 4435_DN | |
| Drug | 5255229; Down 200; 13uM; MCF7; HT_HG-U133A_EA | 2.05e-04 | 198 | 62 | 5 | 949_DN | |
| Drug | tolbutamide | 2.05e-04 | 198 | 62 | 5 | CID000005505 | |
| Drug | Furosemide [54-31-9]; Down 200; 12uM; HL60; HG-U133A | 2.10e-04 | 199 | 62 | 5 | 1580_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 1502_DN | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 5688_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 2266_UP | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.14e-04 | 200 | 62 | 5 | 4094_UP | |
| Drug | genistein; Up 200; 10uM; PC3; HT_HG-U133A | 2.14e-04 | 200 | 62 | 5 | 1235_UP | |
| Disease | 4-hydroxyphenylpyruvate measurement | 2.43e-05 | 4 | 60 | 2 | EFO_0800120 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 8.67e-05 | 42 | 60 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | Brain hemorrhage | 1.81e-04 | 10 | 60 | 2 | C0553692 | |
| Disease | decadienedioic acid (C10:2-DC) measurement | 1.81e-04 | 10 | 60 | 2 | EFO_0800598 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAHVLRKPIFGRYKP | 366 | Q9H0X4 | |
| KCPLHTVLKLTPVAY | 416 | P16118 | |
| PLHTIFKLTPVAYGC | 416 | O60825 | |
| VVILTPLLCSHPKYR | 236 | Q96DZ1 | |
| KGCFYTHPTEVLKPV | 341 | Q03989 | |
| YVCRPAIKTTIKHPR | 106 | Q9NR48 | |
| KTHPHFVIPYRCLVG | 106 | P05067 | |
| TTILGICRPIKPIYK | 11 | Q5T3Y7 | |
| SLPGHPDCKTIRIIY | 491 | Q9Y2E6 | |
| DLPIKIYGRIIPCKH | 61 | Q8N7E2 | |
| NYRHKPLKLECPVAG | 136 | P0C864 | |
| TIYGKICHFRKPPVL | 291 | Q8WWL7 | |
| LGFPYIKPCKLVHLQ | 486 | Q8TBY9 | |
| MLGSKPRVHLYILPC | 1 | Q8NGE7 | |
| VYFPRLIVPFCGHIK | 31 | Q3ZCW2 | |
| IGRPLHYPVLVTKAC | 131 | Q6IF63 | |
| CPLSKGFQYIRVHVP | 156 | Q4G0Z9 | |
| FRAHIPPLGLKVYKI | 706 | Q16706 | |
| PPRHFTGGKIYKVCP | 1051 | Q12766 | |
| KTKPHLFYIPGRMCP | 236 | Q9H307 | |
| CPRMTLPAKYGIIIH | 226 | Q96LB8 | |
| VKHPPSVKYARCFLS | 61 | Q96G04 | |
| KCPLHTVLKLTPVAY | 411 | Q16875 | |
| PLHTVLKLTPVAYGC | 416 | Q16877 | |
| FRCSYVPTKPIKHTI | 726 | Q14315 | |
| LGEVCHLYYPKVPRT | 121 | P49279 | |
| FRIPLSPVHKCSFYK | 716 | P22413 | |
| EILRDPCFHPGYKKV | 276 | P49961 | |
| FPKKSGPVVLYFCVR | 86 | Q9P2Q2 | |
| LQLVCHVSGFYPKPV | 226 | P15812 | |
| KQVKIGSPYCLHLRV | 106 | Q9HCM4 | |
| YKHFTCNVLPRIKGL | 216 | Q04446 | |
| DPYVKLHLLPGACKA | 126 | Q14183 | |
| SKCKEGRPVYISLPH | 331 | P16671 | |
| YFGKRPPGVLHCTTK | 241 | P09543 | |
| YIKIKVGPKVLGPFC | 246 | P48740 | |
| PPVLKGRKYTLRCHV | 141 | Q14773 | |
| ICKPLHYKRILTPQV | 156 | Q8NH67 | |
| KRLPYCKGNVIPHTY | 166 | Q8NH53 | |
| ACIIGYLEIHPAKKP | 531 | Q9BTC8 | |
| KTLHPLCPVFQLGYV | 221 | P51575 | |
| FCSGLAPHFPIKKVL | 256 | Q9ULQ0 | |
| KIPKTLVPHYCELVG | 231 | Q96KG9 | |
| GTIRVPAPCKYAHKL | 936 | Q8TC59 | |
| RLPPKKVPGFCSFRY | 6 | Q14916 | |
| YVHLKKRFCEGPSEP | 76 | Q53LP3 | |
| VKIHPSYCGPAILRF | 86 | Q7Z3Z2 | |
| DCRIHFKKYGELPPI | 531 | Q9P2R6 | |
| PIRGRPKKCLVYPHA | 31 | Q8NEY3 | |
| IVHRKILPGEKPYKC | 356 | Q9HBT7 | |
| FKPPKVTFRTRIYHC | 116 | Q96LR5 | |
| RLCILKGIYPHEPKH | 36 | O00541 | |
| GKLHTIPIPVARCYT | 276 | Q8WYR1 | |
| ITFLKYIPICPVFKG | 556 | Q9UHI7 | |
| SIQPCPDVKYGKRIH | 101 | P55072 | |
| VFVQCRHPPALRGKY | 386 | Q7L0X0 | |
| GHPFLKKCTIESIFP | 76 | Q92800 | |
| GIIKLVIHFRMYCPP | 46 | Q8N8P6 | |
| PVCQPHPVYRLKLKF | 706 | Q13472 | |
| PEKPYKGSGFRCIHI | 46 | P50616 | |
| IRLKPGHVPYCDLCK | 61 | Q9HBF4 | |
| CLLGPTLKKRYPTVH | 536 | Q4KMQ1 | |
| VHKKRKCPGPIITYH | 201 | Q15906 | |
| IPIRPCVLKYLGKTH | 2686 | Q9Y4A5 | |
| CKVHIRVYLPPLDSG | 636 | Q9ULE0 |